Caroline D. Dorsa's most recent trade in Illumina Inc was a trade of 2,072 Common Stock done at an average price of $144.8 . Disclosure was reported to the exchange on May 20, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Illumina Inc | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 144.83 per share. | 20 May 2026 | 2,072 | 15,754 (0%) | 0% | 144.8 | 300,088 | Common Stock |
| Illumina Inc | Caroline D. Dorsa | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 141.92 per share. | 20 May 2026 | 1,512 | 13,682 (0%) | 0% | 141.9 | 214,583 | Common Stock |
| Duke Energy | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 124.87 per share. | 07 May 2026 | 1,602 | 12,723 (0%) | 0% | 124.9 | 200,042 | Common Stock |
| Biogen | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 3,160 | 31,002 (0%) | 0% | 0 | Common Stock | |
| Illumina Inc | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 3,780 | 15,194 (0%) | 0% | 0 | Common Stock | |
| Illumina Inc | Caroline D. Dorsa | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.62 per share. | 16 May 2025 | 1,070 | 11,414 (0%) | 0% | 83.6 | 89,473 | Common Stock |
| Biogen | Caroline D. Dorsa | Director | Purchase of securities on an exchange or from another person at price $ 122.72 per share. | 02 May 2025 | 1,235 | 27,842 (0%) | 0% | 122.7 | 151,559 | Common Stock |
| Duke Energy | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 121.33 per share. | 01 May 2025 | 1,607 | 11,121 (0%) | 0% | 121.3 | 194,977 | Common Stock |
| Biogen | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 1,785 | 26,607 (0%) | 0% | 0 | Common Stock | |
| Illumina Inc | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 2,622 | 12,431 (0%) | 0% | 0 | Common Stock | |
| Illumina Inc | Caroline D. Dorsa | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 115.01 per share. | 15 May 2024 | 612 | 9,809 (0%) | 0% | 115.0 | 70,386 | Common Stock |
| Duke Energy | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 103.06 per share. | 09 May 2024 | 1,698 | 9,514 (0%) | 0% | 103.1 | 175,000 | Common Stock |
| Biogen | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2023 | 1,580 | 24,822 (0%) | 0% | 0 | Common Stock | |
| Illumina Inc | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 1,532 | 10,421 (0%) | 0% | 0 | Common Stock | |
| Illumina Inc | Caroline D. Dorsa | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 212.65 per share. | 24 May 2023 | 492 | 8,889 (0%) | 0% | 212.7 | 104,624 | Common Stock |
| Duke Energy | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 98.15 per share. | 04 May 2023 | 1,783 | 7,816 (0%) | 0% | 98.1 | 175,000 | Common Stock |
| Biogen | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 1,370 | 23,242 (0%) | 0% | 0 | Common Stock | |
| Intellia Therapeutics Inc | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 7,688 | 7,688 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 5,197 | 12,701 (0%) | 0% | 0 | Common Stock | |
| Duke Energy | Caroline D. Dorsa | Director | Grant, award, or other acquisition of securities at price $ 110.05 per share. | 05 May 2022 | 1,590 | 6,031 (0%) | 0% | 110.1 | 174,980 | Common Stock |